Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |